In this prerecorded webinar, Martin Lush, President of NSF Health Sciences Pharma Biotech, explains the problems faced by most pharmaceutical companies when it comes to human error and provides some quick steps to reduce it.

The Problem

  • Regulators are intolerant of “human error” as a genuine cause of most deviations. And rightly so! In our opinion, human error is the consequence, not the cause, of incidents; the starting point of an investigation, rarely the conclusion.
  • How do you investigate so-called human error incidents?
  • How do you error-proof your systems and procedures?

What You Will Learn

  • The top five reasons people make mistakes
  • Five key steps you can immediately take to reduce the frequency and magnitude of human error
  • Access to more references and information to help you reduce human error